367 related articles for article (PubMed ID: 23460037)
1. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
Duncan EM; Rodgers SE; McRae SJ
Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
[TBL] [Abstract][Full Text] [Related]
4. Assay discrepancy in mild haemophilia A.
Armstrong E; Hillarp A
Eur J Haematol Suppl; 2014 Aug; 76():48-50. PubMed ID: 24957107
[TBL] [Abstract][Full Text] [Related]
5. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
6. Tyr346-->Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A?
Lyall H; Hill M; Westby J; Grimley C; Dolan G
Haemophilia; 2008 Jan; 14(1):78-80. PubMed ID: 18034822
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
Rodgers S; Duncan E
Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
[TBL] [Abstract][Full Text] [Related]
8. One-stage vs. chromogenic assays in haemophilia A.
Potgieter JJ; Damgaard M; Hillarp A
Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays.
Valikhani A; Mirakhorly M; Namvar A; Rastegarlari G; Toogeh G; Shirayeh FV; Ahmadinejad M
Transfus Apher Sci; 2021 Oct; 60(5):103194. PubMed ID: 34275734
[TBL] [Abstract][Full Text] [Related]
10. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
[TBL] [Abstract][Full Text] [Related]
11. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
[TBL] [Abstract][Full Text] [Related]
13. Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.
Strålfors A; Mikovic D; Schmidt D; Onelöv L; Soutari NMH; Berndtson M; Chaireti R; Holmström M; Antovic JP; Bruzelius M
Thromb Haemost; 2021 Jan; 121(1):27-35. PubMed ID: 32791533
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
[TBL] [Abstract][Full Text] [Related]
15. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
Mazurier C; Parquet-Gernez A; Goudemand M
Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
[TBL] [Abstract][Full Text] [Related]
16. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.
Bowyer AE; Van Veen JJ; Goodeve AC; Kitchen S; Makris M
Haematologica; 2013 Dec; 98(12):1980-7. PubMed ID: 23812942
[TBL] [Abstract][Full Text] [Related]
17. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.
Poulsen AL; Pedersen LH; Hvas AM; Poulsen LH; Thykjaer H; Ingerslev J
Haemophilia; 2009 Jan; 15(1):285-9. PubMed ID: 19149854
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
Baig MA; Swamy KB
Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
[TBL] [Abstract][Full Text] [Related]
19. Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype.
Oldenburg J; Pavlova A
Hamostaseologie; 2010 Nov; 30(4):207-11. PubMed ID: 21057709
[TBL] [Abstract][Full Text] [Related]
20. Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.
Saito T; Mukae J; Nakamura Y; Inaba H; Nogami K; Koyama T; Fukutake K; Yamamoto K
Intern Med; 2017; 56(13):1719-1723. PubMed ID: 28674365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
